companydata.dkFamilien Andresens selskab til fremme af medicinsk forskning A/S: Financial statements 2023
CVR: 39694395
Familien Andresens selskab til fremme af medicinsk forskning A/S (CVR 39694395) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -7,512,250 and a net result of DKK -4,931,284 compared with DKK -4,781,247 the year before. Equity amounted to DKK 26,152,393. The solvency ratio was 77.7%. The company had 1 employee in the financial year.
- Gross Profit
- -7,512,250 kr.
- Profit/Loss
- -4,931,284 kr.
- Equity
- 26,152,393 kr.
- Total Assets
- 33,677,394 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -7.5 mio. | -4.9 mio. | 26.2 mio. | 1 |
| 2022 | - | -7.5 mio. | -4.8 mio. | 31.1 mio. | 0 |
| 2021 | - | -7.5 mio. | -4.6 mio. | 35.9 mio. | 0 |
| 2020 | - | -5.5 mio. | -3 mio. | 40.5 mio. | 0 |
| 2019 | - | -5.5 mio. | -2.9 mio. | 43.5 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Familien Andresens selskab til fremme af medicinsk forskning A/S has published its annual report for 2022. Gross profit came to DKK -7,511,875, and the net result was DKK -4,781,247.
As of April 25, 2023, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of Familien Andresens selskab til fremme af medicinsk forskning A/S.
As of April 25, 2023, 18. juni 2024 P/S has stepped down as auditor of Familien Andresens selskab til fremme af medicinsk forskning A/S.
About Familien Andresens selskab til fremme af medicinsk forskning A/S
Familien Andresens selskab til fremme af medicinsk forskning A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 2018. The company is registered under the industry Investering for egen regning. The management consists of Jørgen Jacobsen. The company is owned by CALLIE INVEST A/S. In 2025, the company reported a gross profit of DKK -25,521,250 and a net result of DKK -19,380,900 compared with DKK -6,685,198 the year before. Equity amounted to DKK 86,296.